- Wichita Falls TX Drug & Alcohol Rehab 940-228-1766
- GU Students on ‘Indefinite Probation’ for Violating Weapons Policy
- Help for Family Members of Alcoholics
- Alcoholism Treatment Massachusetts – Watch Drug Rehab Video
- Documentaries: Watch Online at Documentary Addict
- Working in Drug/addiction Rehab Centers?
- Overcome Video Game Addiction and Stop Playing
- Where Can I Find State Funded Drug Rehab Programs ?
- Saturday's Sports Transactions
- Drug Addiction Help Hotline (888) 978-4179
- 13. Is Treatment for Drug Addiction Effective?
- Addiction Recovery — Alcohol and Drug Abuse Treatment Resources
- Robert Lefever Interviews. Prescription Drug Addiction – Lower Prescribing Rates Through Counselling
Yale Opens Cancer Center at Greenwich Hospital
Yale opens cancer center at Greenwich Hospital
Filed under: drug treatment programs in maryland
From left, Thomas J. Lynch, Jr., MD, director of Yale Cancer Center and physician-in-chief of the Smilow Cancer Center at Yale New Haven, Frank Corvino, president & CEO of Greenwich Hospital and Dickerman Hollister, Jr., medical director of the …
Read more on Greenwich Time
LSUHSC research provides new drug target for Her-2 related breast cancer
Filed under: drug treatment programs in maryland
"This study will be helpful in developing novel breast cancer therapeutic drugs that target mciroRNAs in breast cancer patients." Excluding skin cancer, breast cancer is the most common type of … Mammography can often detect breast cancer at an early …
Read more on EurekAlert (press release)
Our shifting awareness
Filed under: drug treatment programs in maryland
Our economy is dependent on the labor of these "non-recognized" people whom we so often overlook and treat as non-entities. This is a complex and … Mass incarceration that flows from the "War on Drugs" finds 2.3 million people in the U.S. behind bars …
Read more on Bennington Banner
Echo to Report Trial Results of Symphony tCGM System; Telik Reports Deal on …
Filed under: drug treatment programs in maryland
The poster, entitled "Accuracy of a Novel Non-Invasive Transdermal Continuous Glucose Monitor in Critically Ill Patients," presented by the principal investigator, Stanley A. Nasraway, M.D., FCCM, provided data from fifteen (15) patients who were …
Read more on Equities.com